Brendan Manning, Ph.D.
Brendan Manning, Ph.D.
Professor and Acting Chair, Department of Molecular Metabolism (Harvard T.H. Chan School of Public Health
Affiliate Member of Cell Biology (HMS)

Brendan Manning, Ph.D. is a Professor and Acting Chair in the Department of Molecular Metabolism at the Harvard T.H. Chan School of Public Health. He received his PhD from Yale University in 2000 and was a postdoctoral fellow at Harvard Medical School. In 2004, Dr. Manning became the first faculty member hired in the then newly established Department of Genetics and Complex Diseases (later changed to Molecular Metabolism) at Harvard-Chan. Dr. Manning was an inaugural recipient of the National Cancer Institute’s Outstanding Investigator Award. 

Research in the Manning lab is defining the molecular interface between cellular signaling networks and metabolic networks, as it relates to both normal physiology and diseases with metabolic dysregulation as a key feature, including cancer, diabetes, and aging-related diseases. Research efforts are focused in part on defining the regulatory mechanisms and functions of a signaling network converging on the tuberous sclerosis complex (TSC) protein complex and the mammalian target of rapamycin (mTOR), which relay an array of extracellular and intracellular growth signals to control the balance between anabolic and catabolic metabolism in cells, tissues, and tumors.

665 Huntington Ave


Boston, MA 02115

IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex.
Authors: Authors: Valvezan AJ, McNamara MC, Miller SK, Torrence ME, Asara JM, Henske EP, Manning BD.
JCI Insight
View full abstract on Pubmed
The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism.
Authors: Authors: Hoxhaj G, Manning BD.
Nat Rev Cancer
View full abstract on Pubmed
Fibroblastic reticular cells enhance T cell metabolism and survival via epigenetic remodeling.
Authors: Authors: Brown FD, Sen DR, LaFleur MW, Godec J, Lukacs-Kornek V, Schildberg FA, Kim HJ, Yates KB, Ricoult SJH, Bi K, Trombley JD, Kapoor VN, Stanley IA, Cremasco V, Danial NN, Manning BD, Sharpe AH, Haining WN, Turley SJ.
Nat Immunol
View full abstract on Pubmed
Author Correction: Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis.
Authors: Authors: Liu P, Gan W, Inuzuka H, Lazorchak AS, Gao D, Arojo O, Liu D, Wan L, Zhai B, Yu Y, Yuan M, Kim BM, Shaik S, Menon S, Gygi SP, Lee TH, Asara JM, Manning BD, Blenis J, Su B, Wei W.
Nat Cell Biol
View full abstract on Pubmed
Direct stimulation of NADP+ synthesis through Akt-mediated phosphorylation of NAD kinase.
Authors: Authors: Hoxhaj G, Ben-Sahra I, Lockwood SE, Timson RC, Byles V, Henning GT, Gao P, Selfors LM, Asara JM, Manning BD.
View full abstract on Pubmed
Molecular logic of mTORC1 signalling as a metabolic rheostat.
Authors: Authors: Valvezan AJ, Manning BD.
Nat Metab
View full abstract on Pubmed
Ex vivo and in vivo stable isotope labelling of central carbon metabolism and related pathways with analysis by LC-MS/MS.
Authors: Authors: Yuan M, Kremer DM, Huang H, Breitkopf SB, Ben-Sahra I, Manning BD, Lyssiotis CA, Asara JM.
Nat Protoc
View full abstract on Pubmed
Signalling protein protects the heart muscle from pressure-related stress.
Authors: Authors: Manning BD.
View full abstract on Pubmed
Lysosomal catch-and-release controls mTORC1.
Authors: Authors: Hosios AM, Manning BD.
Nat Cell Biol
View full abstract on Pubmed
Amino Acid Restriction Triggers Angiogenesis via GCN2/ATF4 Regulation of VEGF and H2S Production.
Authors: Authors: Longchamp A, Mirabella T, Arduini A, MacArthur MR, Das A, Treviño-Villarreal JH, Hine C, Ben-Sahra I, Knudsen NH, Brace LE, Reynolds J, Mejia P, Tao M, Sharma G, Wang R, Corpataux JM, Haefliger JA, Ahn KH, Lee CH, Manning BD, Sinclair DA, Chen CS, Ozaki CK, Mitchell JR.
View full abstract on Pubmed